Frontlight ResearchEarly access
Peripheral artery disease trials, also abroad
233 open Peripheral artery disease trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
The same trial often runs in several countries
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) has 7 sites in Germany and runs in 35 countries. If a site near you is full, another one may still take people.
See Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) in all 35 countries